Ranny Yaffe
Amministratore Delegato presso VESSL Therapeutics Ltd.
Profilo
Ranny Yaffe is currently the Co-Chief Executive Officer at VESSL Therapeutics Ltd.
He started this position in 2020.
Prior to his current role, Mr. Yaffe obtained an undergraduate degree and an MBA from Technion-Israel Institute of Technology.
Posizioni attive di Ranny Yaffe
| Società | Posizione | Inizio |
|---|---|---|
VESSL Therapeutics Ltd.
 VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Amministratore Delegato | 01/01/2020 |
Formazione di Ranny Yaffe
| Technion-Israel Institute of Technology | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
VESSL Therapeutics Ltd.
VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Health Technology |
- Borsa valori
- Insiders
- Ranny Yaffe
